
Advertise on podcast: QCast: Data-Driven Dialogue in Drug Development
This podcast has
72 episodes
Language
EnglishPublisher
QuanticateExplicit
No
Date created
2025/06/03
Latest episode
2026/11/13
Average duration
12 min.
Release period
7 days
Description
QCast by Quanticate is the podcast for biotech, pharma, and life science leaders looking to deepen their understanding of biometrics and modern drug development. Join co-hosts Tom and Jullia as they explore methodologies, case studies, regulatory shifts, and industry trends shaping the future of clinical research. Where biometric expertise meets data-driven dialogue, QCast delivers practical insights and thought leadership to inform your next breakthrough.
Unlock QCast: Data-Driven Dialogue in Drug Development podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from QCast: Data-Driven Dialogue in Drug Development podcast
Episode 72: Group Sequential Designs in Clinical Trials
2026/11/13
In this QCast episode, co-hosts Jullia and Tom discuss group sequential designs in clinical trials, where pre-planned interim analyses allow a study to stop early for efficacy, stop for futility, or continue to the next look.
Key Takeaways
Interim looks are usually timed by information fraction, the share of planned statistical information collected so far. A look is only worth including if its result would change a decision.Stopping boundaries such as O’Brien–Fleming and Pocock set different evidence thresholds at each look. Alpha spending keeps the overall false-positive risk controlled across all planned analyses.A design can look attractive on paper and still need an implausible treatment effect to cross its first boundary. Clean, timely data and controlled access to interim results matter as much as the statistics.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 71: What is a Clinical Development Plan?
2026/11/06
A clinical development plan should connect the evidence a programme needs with its studies, decision points, regulatory interactions and resources. In this QCast episode, co-hosts Jullia and Tom examine how a well-structured CDP turns clinical development strategy into an executable programme, while allowing teams to respond to emerging data without losing scientific discipline.
Key Takeaways
Each study should address a defined gap or support a clear programme decision.Predefined measures, thresholds and actions help teams assess results consistently while retaining credible alternative paths.Regulatory, safety, operational and resourcing assumptions should be reviewed after major data readouts, authority interactions and programme decisions.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 70: Clinical Trial Planning and Design
2026/10/30
Clinical trial design decisions can have consequences across the protocol, analysis and delivery of a study. In this QCast episode, co-hosts Jullia and Tom examine how a clear research question should guide the study population, endpoints, comparator and statistical approach.
Key Takeaways
A specific treatment objective helps ensure that the design, endpoint and comparator address the clinical decision the study needs to support.Sample size and analysis assumptions should be tested while the protocol can still be adjusted, then revisited when the endpoint, schedule, or participant burden changes.Recruitment potential, site capability, and the demands placed on participants can directly affect adherence, missing data, and dropout.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 69: SDTM Mapping Automation Tool
2026/10/23
In this QCast episode, co-hosts Jullia and Tom examine how SDTM mapping automation tools use approved rules and metadata to generate mapping specifications and SAS code, and where AI can assist with unfamiliar variables.
Key Takeaways
Approved mappings can be reused across studies and updated when protocol requirements change, reducing repetitive programming.ML can suggest mappings for unfamiliar variables, but recommendations still require review against the source data and study requirements.Passing automated validation checks doesn't necessarily mean a dataset accurately represents the collected data. Independent QC remains essential.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 68: AI in Clinical Trial Design
2026/10/16
AI and machine learning can help research teams make more informed clinical trial design decisions, from assessing protocol feasibility to identifying suitable patient populations. In this QCast episode, Jullia and Tom discuss how predictive modelling, natural language processing, and retrospective analysis can support study planning.
Key Takeaways
AI can help identify restrictive eligibility criteria, assess patient burden, and inform protocol feasibility before enrolment.Predictive modelling and retrospective analysis can support patient selection and identify treatment response patterns worth investigating in future trials.AI tools require appropriate validation, representative data, and human oversight, with their value assessed against measurable study outcomes.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 67: The Analysis of Direct and Indirect Pathways in Observational Studies
2026/10/09
In this episode, Jullia and Tom discuss direct and indirect pathways in observational studies, with a focus on mediation analysis and what it can, and cannot, show. Using an ankylosing spondylitis example, they look at how fatigue, anxiety/depression, and work productivity loss can be mapped as exposure, mediator, and outcome, and why interpretation needs care when the data are observational.
Key Takeaways
Direct and indirect pathways in this context refer to mediation analysis, not basal ganglia movement-control circuits.Mediation analysis can help examine whether an observed relationship may operate through an intermediate variable, but it does not prove causality on its own.The practical value of pathway analysis depends on clear hypotheses, suitable variable measurement, uncertainty assessment, and careful interpretation.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 66: What is Clinical Traceability?
2026/10/02
Clinical traceability is about being able to follow evidence from a reported result back to its source and understand the transformations, decisions, and records in between. In this QCast episode, co-hosts Jullia and Tom discuss how traceability can become harder when studies involve multiple systems, CROs, laboratories, and technology providers, and why retaining files alone is not enough.
Key Takeaways
Strong traceability connects reported results with the underlying data, derivations, programs, and supporting decisions, rather than relying on file retention alone.Outsourced studies can increase traceability complexity because data and responsibilities are distributed across several organisations and systems.A practical review can work in both directions: start with an important result and trace it back to source, then start with a source variable or external data stream and identify which analyses depend on it.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 65: Clinical Trial Trends Shaping Modern Drug Development
2026/09/25
Clinical trial trends matter most when they affect how studies are designed, delivered, and overseen. In this QCast episode, co-hosts Jullia and Tom discuss how decentralised models, AI, real-world evidence, adaptive designs, RBQM, outsourcing, and digital trial systems are changing practical decisions for sponsors and CROs.
Key Takeaways
New trial models can reduce participant burden, but they may add validation, oversight, and data-quality requirements elsewhere.AI and automation work best in clearly defined use cases with human review, documented controls, and clear accountability.Trial design, site readiness, outsourcing, and digital data flows all need to be assessed against the study question, patient population, and operational risk.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 64: Tipping Point Analysis in Clinical Trials
2026/09/18
Tipping point analysis helps trial teams understand how strongly a study conclusion depends on assumptions about missing data. In this QCast episode, co-hosts Jullia and Tom discuss how the method relates to MAR and MNAR, how delta adjustments can identify a tipping point, and why the numerical result still needs clinical interpretation.
Key Takeaways
Tipping point analysis tests how far assumptions about missing outcomes must change before a predefined trial conclusion changes.The tipping point needs to be interpreted in clinical context, including the endpoint scale, reasons for missingness, and number of participants affected.Continuous, binary, and time-to-event endpoints require different approaches, and prespecification helps keep the analysis aligned with the intended clinical question.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 63: Audit Trail Review in Clinical Trials
2026/09/11
Audit trail review can involve far more than checking whether a system records changes. In this QCast episode, co-hosts Jullia and Tom discuss how trial teams can decide what needs review, where risk should shape scope and timing, and why unusual activity needs context before it becomes a finding.
Key Takeaways
Audit trail review should focus on relevant risks and questions rather than attempting to review every available event.Trial-level and system-level review can have different purposes and owners, so scope and responsibilities need to be clear.A flagged event still needs interpretation against the clinical data and study context before deciding whether action is required.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 62: Drug Adherence and Persistence
2026/09/04
Drug adherence and persistence measures built from claims or EHR databases depend as much on study definitions as recorded treatment events. In this QCast episode, co-hosts Jullia and Tom explain how adherence differs from persistence, what prescribing and dispensing data can and cannot show, and how MPR, PDC, treatment-gap rules and thresholds shape the findings.
Key Takeaways
Adherence describes how closely medicine use follows the agreed regimen, while persistence measures how long treatment continues before discontinuation.Claims and EHR data provide useful evidence on prescriptions, dispensing and treatment changes, but neither confirms that a patient took the medicine as intended.MPR, PDC and persistence estimates depend on decisions about follow-up, days’ supply, permissible gaps, dose changes, switching and censoring.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 61: The Role of Data Monitoring Committees (DMC) in Clinical Trials
2026/08/28
In this QCast episode, Jullia and Tom discuss the role of data monitoring committees, or DMCs, in clinical trials. They explain how DMCs support participant safety and trial integrity, when independent monitoring may be proportionate, and why confidential interim data needs careful handling.
Key Takeaways
A DMC provides independent review of accumulating trial data, especially where interim safety, efficacy, futility or benefit-risk decisions may affect study conduct.DMCs are not automatically needed for every trial. Their use should be assessed against the study’s risk profile, design, duration, blinding and planned interim decision points.Clear charters, controlled data access and independent statistical support help protect confidential interim data and reduce the risk of operational bias.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 60: Oncology Phase 1 Trial Design
2026/08/21
In this QCast episode, Jullia and Tom discuss how oncology Phase 1 trial design has moved beyond simply identifying the maximum tolerated dose. They look at dose optimisation, escalation methods, simulation, data readiness, expansion cohorts, biomarkers and site capability, with a focus on how these elements affect real dose decisions.
Key Takeaways
Safety, exposure, pharmacodynamic information, early activity and longer-term tolerability can all influence the dose and regimen taken forward.Simulation can show how a design behaves when toxicity is delayed, information is incomplete or patients are exposed to doses that are too high or too low.Adverse events, laboratory results, PK and PD data, query resolution, biomarker turnaround and site readiness can all affect whether reviews happen with the evidence expected.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 59: Clinical Data Quality
2026/08/14
In this QCast episode, Jullia and Tom look at how clinical data quality is shaped from study set-up through collection, review and integration. They discuss why clear definitions, well-designed data flows and proportionate quality control matter, particularly when trial data move across multiple systems or vendors.
Key Takeaways
Clinical data should be judged by whether they are fit for the decisions and analyses the study needs to support, rather than by cleanliness alone.Quality problems often begin upstream. CRF design, data definitions, mappings and study instructions can create issues that later queries cannot fully correct.Review effort should focus on critical data and recurring patterns. Trend review can help identify process problems that isolated record checks may miss.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Episode 58: Rescue Studies
2026/08/07
In this QCast episode, Jullia and Tom discuss how sponsors can assess a study in difficulty, decide how to handle existing databases and data, manage handovers, and set realistic expectations for recovery.
Key Takeaways
A rescue assessment should identify the root cause before corrective work begins.Database rescue does not always require a rebuild.Recovery plans need to reflect what can genuinely be corrected.
🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.
About Quanticate
Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:
Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.
Podcast reviews
Read QCast: Data-Driven Dialogue in Drug Development podcast reviews
Podcast sponsorship advertising
Start advertising on QCast: Data-Driven Dialogue in Drug Development relevant audience podcasts
You may also like to advertise on these Podcasts

4.975261756
Small Town Murder
James Pietragallo, Jimmie Whisman

4.71325596
Bulwark Takes
The Bulwark

4.8583398
Didn't I Just Feed You
Stacie Billis and Meghan Splawn

4.4503509
Warfare
History Hit

4.8296932000
Fantasy Footballers - Fantasy Football Podcast
Fantasy Football

4.712851555
True Crime All The Time
Emash Digital

4.8160231996
Watch What Crappens
Ben Mandelker & Ronnie Karam

4.639261172
Modern Wisdom
Chris Williamson

4.66262310
True Crime with Kendall Rae
Mile Higher Media & Audioboom Studios

4.73454788
The Ancients
History Hit